Backing breakthroughs in biotech, tech, and digital assets

Gene editing and RNA therapies shaping medicine

Next-gen software and scalable SaaS platforms

Cryptocurrency infrastructure and digital assets

Close-up of a scientist working with gene editing tools in a lab
Close-up of a scientist working with gene editing tools in a lab
Abstract digital interface representing advanced software architecture
Abstract digital interface representing advanced software architecture
Visual of blockchain nodes symbolizing cryptocurrency infrastructure
Visual of blockchain nodes symbolizing cryptocurrency infrastructure

Investing at the Edge

At Greymont Private Capital, we focus on breakthrough science and technology shaping tomorrow’s industries.

A sleek modern office space with a view of a European city skyline, symbolizing innovation and precision.
A sleek modern office space with a view of a European city skyline, symbolizing innovation and precision.
Our Focus
Our Approach

We partner with visionary founders and funds, backing clear paths to value through hands-on, selective investments.

Our Focus

Investing in breakthroughs shaping tomorrow’s biotech, tech, and media.

Close-up of laboratory equipment displaying gene editing process in action.
Close-up of laboratory equipment displaying gene editing process in action.
Dynamic cityscape blending digital technology and creative media elements.
Dynamic cityscape blending digital technology and creative media elements.
Biotech

Backing rare-disease therapeutics and pioneering gene and enzyme platforms.

Technology

Supporting SaaS models, advanced software, and scalable digital infrastructure.

Questions? Reach out anytime.